Zhongguancun: Notice on the receipt of the “Notice of Acceptance” of the subsidiary company Beijing Huasu Naloxone Hydrochloride Injection and the Shandong Huasu Metoprolol Succinate API application

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.